FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000163729> ?p ?o ?g. }

• W2000163729 abstract "Dose-response curves for the inhibition of heterogeneous nuclear RNA (hnRNA) synthesis in HeLa cells by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB; 5-100 microM; 30 min) are biphasic and indicate the existence of two subpopulations of hnRNA molecules, one highly sensitive and the other completely resistant, as previously reported for molecules greater than 1,000 nucleotides long (Tamm et al., 1976; Sehgal et al., 1976a). In the short-term experiments, the drug-sensitive synthesis of hnRNA was inhibited 50% at a DRB concentration of approximately 7 microM, and 70% at 20 microM, whereas drug-resistant synthesis, which comprises approximately 20% of total, continued at DRB concentrations as high as 100 microM. After 24 hr of DRB treatment in medium containing 5% fetal calf serum, the increase in cell number in the exponentially growing population was inhibited by only 42% at 20 microM DRB, and the formation of colonies of greater than or equal to ten cells was not decreased. DRB at 40 microM concentration decreased population growth by 76% and colony formation by 63%. Treatment with 60 microM DRB was sufficient to prevent a net increase in cell number and to reduce colony formation by 78%. After termination of treatment, the time required for the surviving population to begin rapid proliferation was directly related to the concentration of DRB used to treat cells and to the duration of treatment. After 24-hr treatment with 40 microM DRB, cultures recovered within 1 day, whereas after 60 microM DRB, 3-4 days were required. After 40-hr treatment with 60 microM DRB, 5-6 days were required for recovery, and after 80 microM DRB, 9-11 days. During the dormant period the cell number ranged from 15 to 60% of the initial number and was fairly stable for given conditions. After the dormant period, recovery was rapid. The population growth rate in cultures undergoing treatment with DRB is directly related to serum concentration; however, the recovery rate during the post-treatment period is unaffected by serum concentration." @default.
• W2000163729 created "2016-06-24" @default.
• W2000163729 creator A5069275249 @default.
• W2000163729 date "1983-07-01" @default.
• W2000163729 modified "2023-09-23" @default.
• W2000163729 title "Recovery of HeLa cell population growth after treatment with 5,6-dichloro-1-?-D-ribofuranosylbenzimidazole (DRB)" @default.
• W2000163729 cites W1528041508 @default.
• W2000163729 cites W152930514 @default.
• W2000163729 cites W1562475668 @default.
• W2000163729 cites W1963553127 @default.
• W2000163729 cites W1965977492 @default.
• W2000163729 cites W1968968063 @default.
• W2000163729 cites W1982512873 @default.
• W2000163729 cites W1989822048 @default.
• W2000163729 cites W2031719530 @default.
• W2000163729 cites W2033280619 @default.
• W2000163729 cites W2033630367 @default.
• W2000163729 cites W2047743900 @default.
• W2000163729 cites W2070098096 @default.
• W2000163729 cites W2087542693 @default.
• W2000163729 cites W2097541313 @default.
• W2000163729 cites W2143034614 @default.
• W2000163729 cites W2257549554 @default.
• W2000163729 cites W2415422935 @default.
• W2000163729 doi "https://doi.org/10.1002/jcp.1041160106" @default.
• W2000163729 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6853610" @default.
• W2000163729 hasPublicationYear "1983" @default.
• W2000163729 type Work @default.
• W2000163729 sameAs 2000163729 @default.
• W2000163729 citedByCount "7" @default.
• W2000163729 countsByYear W20001637292013 @default.
• W2000163729 crossrefType "journal-article" @default.
• W2000163729 hasAuthorship W2000163729A5069275249 @default.
• W2000163729 hasConcept C1491633281 @default.
• W2000163729 hasConcept C153911025 @default.
• W2000163729 hasConcept C185592680 @default.
• W2000163729 hasConcept C2777366897 @default.
• W2000163729 hasConcept C2908647359 @default.
• W2000163729 hasConcept C54355233 @default.
• W2000163729 hasConcept C55493867 @default.
• W2000163729 hasConcept C71924100 @default.
• W2000163729 hasConcept C81885089 @default.
• W2000163729 hasConcept C86803240 @default.
• W2000163729 hasConcept C99454951 @default.
• W2000163729 hasConceptScore W2000163729C1491633281 @default.
• W2000163729 hasConceptScore W2000163729C153911025 @default.
• W2000163729 hasConceptScore W2000163729C185592680 @default.
• W2000163729 hasConceptScore W2000163729C2777366897 @default.
• W2000163729 hasConceptScore W2000163729C2908647359 @default.
• W2000163729 hasConceptScore W2000163729C54355233 @default.
• W2000163729 hasConceptScore W2000163729C55493867 @default.
• W2000163729 hasConceptScore W2000163729C71924100 @default.
• W2000163729 hasConceptScore W2000163729C81885089 @default.
• W2000163729 hasConceptScore W2000163729C86803240 @default.
• W2000163729 hasConceptScore W2000163729C99454951 @default.
• W2000163729 hasLocation W20001637291 @default.
• W2000163729 hasLocation W20001637292 @default.
• W2000163729 hasOpenAccess W2000163729 @default.
• W2000163729 hasPrimaryLocation W20001637291 @default.
• W2000163729 hasRelatedWork W2073729403 @default.
• W2000163729 hasRelatedWork W2363803873 @default.
• W2000163729 hasRelatedWork W2365174857 @default.
• W2000163729 hasRelatedWork W2366399716 @default.
• W2000163729 hasRelatedWork W2378203004 @default.
• W2000163729 hasRelatedWork W2390297373 @default.
• W2000163729 hasRelatedWork W2392725218 @default.
• W2000163729 hasRelatedWork W2414199918 @default.
• W2000163729 hasRelatedWork W2415560385 @default.
• W2000163729 hasRelatedWork W3030991742 @default.
• W2000163729 isParatext "false" @default.
• W2000163729 isRetracted "false" @default.
• W2000163729 magId "2000163729" @default.
• W2000163729 workType "article" @default.